Regulatory FDA Expands AI Capabilities and Completes Data Platform Consolidation FDAFDA announced major steps in its bold initiative to modernize the agency.Read full story pharminent May 6, 2026 (Last updated: May 7, 2026) FDA FDA announced major steps in its bold initiative to modernize the agency. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipelineNext: Halozyme and Oruka sign agreement for Hypercon technology Related Stories Regulatory FDA approves MSD’s Keytruda combinations for MIBC pharminent July 13, 2026 Regulatory FDA freezes CRL trove as ‘radical transparency’ push hits speedbump pharminent July 9, 2026 Regulatory UK first in Europe to clear Boehringer’s IPF drug Jascayd pharminent July 9, 2026
